Related Experiment Videos
Cognitive performance of current methamphetamine and cocaine abusers.
Sara L Simon1, Catherine P Domier, Tiffanie Sim
1UCLA Integrated Substance Abuse Programs (ISAP), USA. slsimon@ucla.edu
Journal of Addictive Diseases
|February 8, 2002
Summary
Methamphetamine (MA) and cocaine (COC) abusers show cognitive impairments compared to non-users. While both stimulant groups were impaired, the specific cognitive deficits differed between methamphetamine and cocaine users.
Area of Science:
- Neuroscience
- Psychology
- Addiction Medicine
Background:
- Chronic psychostimulant use, including methamphetamine (MA) and cocaine (COC), is associated with neurocognitive deficits.
- Understanding the specific cognitive profiles of MA and COC users is crucial for targeted interventions.
Purpose of the Study:
- To compare the cognitive performance of current methamphetamine (MA) abusers and cocaine (COC) abusers against matched non-using control groups.
- To identify differential patterns of cognitive impairment associated with MA versus COC use.
Main Methods:
- Cognitive testing battery administered to 40 MA users, 40 COC users, and 80 matched non-users.
- Questionnaires assessed medical history and stimulant use patterns.
- Control groups were matched for age, education, ethnicity, and gender to respective stimulant user groups.
Main Results:
- Both MA and COC abusers exhibited significant cognitive impairments compared to their matched controls.
- Distinct patterns of cognitive deficits were observed between the MA and COC groups.
- Differences in age and ethnicity between MA and COC users necessitated matched control group design.
Conclusions:
- Methamphetamine and cocaine abuse lead to cognitive impairments, with unique profiles for each substance.
- Cognitive deficits associated with MA and COC use warrant further investigation for clinical implications.
- Matched control designs are essential when comparing distinct stimulant-using populations due to demographic differences.